RVL Pharmaceuticals plc reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Bridgewater, NJ
SEC filing record 1 source field available
Fiscal year end
31 December
RVL Pharmaceuticals plc has filed 323 SEC EDGAR filings since 09 May 2018

SEC filing history

Showing 101-125 of 323 matching filings.

Per page
25
Current page
5
4

OWNERSHIP DOCUMENT

Filing date
20 May 2022
Reporting date
18 May 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
20 May 2022
Reporting date
18 May 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
20 May 2022
Reporting date
18 May 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-38709

DEFA14A

Filing date
25 Apr 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-38709

DEF 14A

Filing date
25 Apr 2022
Reporting date
16 Jun 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
3

OWNERSHIP DOCUMENT

Filing date
22 Apr 2022
Reporting date
18 Apr 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
PRE 14A File 001-38709

PRE 14A

Filing date
12 Apr 2022
Reporting date
16 Jun 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
26 Jan 2022
Reporting date
24 Jan 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
26 Jan 2022
Reporting date
24 Jan 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
26 Jan 2022
Reporting date
24 Jan 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
26 Jan 2022
Reporting date
24 Jan 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
20 Dec 2021
Reporting date
16 Dec 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-260529

EFFECT filing

Filing date
09 Dec 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-38709

DEF 14A

Filing date
08 Dec 2021
Reporting date
14 Jan 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
07 Dec 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .